On the public citation graph

Artificial intelligence enhances whole‐slide interpretation of PD‐L1 CPS in triple‐negative breast cancer: A multi‐institutional ring study

0 signed · 53 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jama.2017.14585openalex-snapshot
Diagnostic Assessment of Deep Learning Algorithms for Detection of Lymph Node Metastases in Women With Breast Cancer
inferredcites →https://doi.org/10.1002/path.5331openalex-snapshot
Computational pathology definitions, best practices, and recommendations for regulatory guidance: a white paper from the Digital Pathology Association
inferredcites →https://doi.org/10.1007/978-3-319-16366-6_1openalex-snapshot
Breast Cancer Survivorship: Where Are We Today?
inferredcites →https://doi.org/10.1007/978-3-319-24574-4_28openalex-snapshot
U-Net: Convolutional Networks for Biomedical Image Segmentation
inferredcites →https://doi.org/10.1007/978-3-319-66179-7_46openalex-snapshot
Suggestive Annotation: A Deep Active Learning Framework for Biomedical Image Segmentation
inferredcites →https://doi.org/10.1007/s10555-021-09972-4openalex-snapshot
Checkpoint inhibitor therapy for metastatic triple-negative breast cancer
inferredcites →https://doi.org/10.1016/1047-3203(90)90014-mopenalex-snapshot
Morphological segmentation
inferredcites →https://doi.org/10.1016/j.apsb.2021.02.007openalex-snapshot
Applying artificial intelligence for cancer immunotherapy
inferredcites →https://doi.org/10.1016/j.bbcan.2021.188520openalex-snapshot
Artificial intelligence and digital pathology: Opportunities and implications for immuno-oncology
inferredcites →https://doi.org/10.1016/j.breast.2021.11.003openalex-snapshot
Interassay and interobserver comparability study of four programmed death-ligand 1 (PD-L1) immunohistochemistry assays in triple-negative breast cancer
inferredcites →https://doi.org/10.1016/j.celrep.2018.03.086openalex-snapshot
Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images
inferredcites →https://doi.org/10.1016/j.media.2016.11.004openalex-snapshot
DCAN: Deep contour-aware networks for object instance segmentation from histology images
inferredcites →https://doi.org/10.1016/j.media.2020.101771openalex-snapshot
NuClick: A deep learning framework for interactive segmentation of microscopic images
inferredcites →https://doi.org/10.1016/j.neucom.2016.01.034openalex-snapshot
A Deep Convolutional Neural Network for segmenting and classifying epithelial and stromal regions in histopathological images
inferredcites →https://doi.org/10.1016/s0140-6736(20)32531-9openalex-snapshot
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial
inferredcites →https://doi.org/10.1038/s41379-021-00904-9openalex-snapshot
Artificial intelligence-assisted system for precision diagnosis of PD-L1 expression in non-small cell lung cancer
inferredcites →https://doi.org/10.1038/s41523-021-00268-yopenalex-snapshot
How can artificial intelligence models assist PD-L1 expression scoring in breast cancer: results of multi-institutional ring studies
inferredcites →https://doi.org/10.1038/s41598-018-37257-4openalex-snapshot
Epithelium segmentation using deep learning in H&E-stained prostate specimens with immunohistochemistry as reference standard
inferredcites →https://doi.org/10.1056/nejmoa1809615openalex-snapshot
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
inferredcites →https://doi.org/10.1056/nejmoa1910549openalex-snapshot
Pembrolizumab for Early Triple-Negative Breast Cancer
inferredcites →https://doi.org/10.1093/bioinformatics/btz083openalex-snapshot
Structured crowdsourcing enables convolutional segmentation of histology images
inferredcites →https://doi.org/10.1097/pap.0000000000000322openalex-snapshot
A Review of Artificial Intelligence in Precise Assessment of Programmed Cell Death-ligand 1 and Tumor-infiltrating Lymphocytes in Non−Small Cell Lung Cancer
inferredcites →https://doi.org/10.1097/pas.0000000000001701openalex-snapshot
SP142 PD-L1 Scoring Shows High Interobserver and Intraobserver Agreement in Triple-negative Breast Carcinoma But Overall Low Percentage Agreement With Other PD-L1 Clones SP263 and 22C3
inferredcites →https://doi.org/10.1109/cvpr.2016.90openalex-snapshot
Deep Residual Learning for Image Recognition
inferredcites →https://doi.org/10.1109/tmi.2021.3081396openalex-snapshot
Domain Adaptation-Based Deep Learning for Automated Tumor Cell (TC) Scoring and Survival Analysis on PD-L1 Stained Tissue Images
inferredcites →https://doi.org/10.1111/his.12904openalex-snapshot
Programmed death ligand 1 expression in triple‐negative breast cancer is associated with tumour‐infiltrating lymphocytes and improved outcome
inferredcites →https://doi.org/10.1111/his.14383openalex-snapshot
Improving Ki67 assessment concordance by the use of an artificial intelligence‐empowered microscope: a multi‐institutional ring study
inferredcites →https://doi.org/10.1111/joim.13030openalex-snapshot
Artificial intelligence as the next step towards precision pathology
inferredcites →https://doi.org/10.1111/tbj.12753openalex-snapshot
Prognostic Value of PD-L1 in Breast Cancer: A Meta-Analysis
inferredcites →https://doi.org/10.1158/1535-7163.mct-14-0983openalex-snapshot
PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
inferredcites →https://doi.org/10.1158/2159-8290.cd-18-1177openalex-snapshot
Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment
inferredcites →https://doi.org/10.1158/2326-6066.cir-13-0127openalex-snapshot
PD-L1 Expression in Triple-Negative Breast Cancer
inferredcites →https://doi.org/10.1186/bcr2615openalex-snapshot
ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67
inferredcites →https://doi.org/10.1186/s12916-019-1326-5openalex-snapshot
Recent advances in triple negative breast cancer: the immunotherapy era
inferredcites →https://doi.org/10.3322/caac.21338openalex-snapshot
Cancer statistics in China, 2015
inferredcites →https://doi.org/10.3322/caac.21492openalex-snapshot
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
inferredcites →https://doi.org/10.3322/caac.21660openalex-snapshot
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
inferredcites →https://doi.org/10.3390/jcm9030749openalex-snapshot
Artificial Intelligence-Based Mitosis Detection in Breast Cancer Histopathology Images Using Faster R-CNN and Deep CNNs
inferredcites →https://doi.org/10.4048/jbc.2020.23.e37openalex-snapshot
Concordance of Programmed Death-Ligand 1 Expression between SP142 and 22C3/SP263 Assays in Triple-Negative Breast Cancer
inferredcites →https://doi.org/10.5858/arpa.2020-0451-oaopenalex-snapshot
Interobserver Variation of PD-L1 SP142 Immunohistochemistry Interpretation in Breast Carcinoma: A Study of 79 Cases Using Whole Slide Imaging

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1002/cai2.159openalex-snapshot
Artificial Intelligence and Breast Cancer Management: From Data to the Clinic
inferred← citeshttps://doi.org/10.1007/s00210-025-03896-4openalex-snapshot
Tailored therapies for triple-negative breast cancer: current landscape and future perceptions
inferred← citeshttps://doi.org/10.1007/s00428-026-04607-xopenalex-snapshot
Clinicopathologic spectrum and diagnostic strategies of intrahepatic neoplasms with prominent inflammatory background
inferred← citeshttps://doi.org/10.1007/s12609-025-00575-4openalex-snapshot
Predictors of Immunotherapy Response in Triple Negative Breast Cancer
inferred← citeshttps://doi.org/10.1016/j.clbc.2025.03.006openalex-snapshot
Harnessing Artificial Intelligence for Precision Diagnosis and Treatment of Triple Negative Breast Cancer
inferred← citeshttps://doi.org/10.1016/j.esmorw.2025.100181openalex-snapshot
Clinical evaluation of an automated pan-organ combined PD-L1 scoring using artificial intelligence on immunostained whole-slide images
inferred← citeshttps://doi.org/10.1016/j.esmorw.2025.100662openalex-snapshot
How artificial intelligence applied to digital pathology could guide treatment personalization in breast cancer
inferred← citeshttps://doi.org/10.1016/j.humpath.2025.105881openalex-snapshot
Emerging molecular Therapeutic targets in breast Cancer: Pathologic identification and clinical implications
inferred← citeshttps://doi.org/10.1016/j.labinv.2026.106121openalex-snapshot
Programmed Death Ligand-1 Testing in Triple-Negative Breast Cancer: National Practice and Interlaboratory Variation in the Netherlands
inferred← citeshttps://doi.org/10.1158/2326-6066.cir-24-1270openalex-snapshot
Artificial Intelligence Can Predict Personalized Immunotherapy Outcomes in Cancer
inferred← citeshttps://doi.org/10.1186/s40164-025-00667-yopenalex-snapshot
Immunotherapy in breast cancer: current landscape and emerging trends
inferred← citeshttps://doi.org/10.3389/fimmu.2025.1614099openalex-snapshot
Automated interpretation of PD-L1 CPS based on multi-AI models integration strategy in gastric cancer
inferred← citeshttps://doi.org/10.3390/cancers18071184openalex-snapshot
Integrating Artificial Intelligence into Breast Cancer Histopathology: Toward Improved Diagnosis and Prognosis
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.